4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022049
Sr. VP, R&D & CSO sold 2,412 shares at $9.63 ($23,228)
From the SEC's structured data for this filing
Trades in this filing
Or Yat Sun · Sr. VP, R&D & CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-05 | Sale : show line 1 in the form | −2,412 | $9.63 | $23,228 | 370,695 | D |
| Open-market sales · 2,412 sh · avg $9.63 · $23,228 | ||||||
Loading xslF345X05/form4.xml…